We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Medicaid Commission Calls for AMP-Based Drug Pricing
Medicaid Commission Calls for AMP-Based Drug Pricing
January 6, 2006
A bipartisan commission has recommended changes to the Medicaid prescription drug reimbursement formula, including new methods of reporting drug prices and penalties for pharmaceutical firms that provide inaccurate pricing information.